The right treatment depends on medical history, goals, risk factors, tolerance, and clinical availability
After providing some background about these drugs, including a brief explanation of how they work, this article will focus on patient care and counseling guidance for RDs
Danuglipron Danuglipron is an oral GLP-1RA developed by Pfizer
This antioxidant rids the body of free radicals, boosts other antioxidants and vitamins, and is critical in cell metabolism
Ready to restore volume, firmness, and glow
(2022) Effect of tirzepatide versus insulin degludec on liver fat content and abdominal adipose tissue in people with type 2 diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial Chao Liao, et al